FOROZA V TERAPII NARUShENIY FOSFORNOKAL'TsIEVOGO OBMENA U BOL'NYKh ENDOKRINNYMI ZABOLEVANIYaMI
- Authors: Kurnikova I.A1
-
Affiliations:
- Issue: No 5 (2014)
- Pages: 72-80
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/286750
- ID: 286750
Cite item
Open Access
Access granted
Abstract
Osteoporosis and other violations of calcium and phosphorus metabolism comprise a significant share in the structure of modern pathology. The article puts emphasis on the manifestation of disorders of mineral metabolism in endocrine diseases and methods of their correction. The basic clinical and laboratory manifestations of disorders of mineral metabolism in hyper- and hypoparathyroidism, diabetes, in thyroid gland and adrenal insufficiency, and in patients with estrogen and androgen deficiency are described. Evidence of high efficiency and a wide range of applications of drug Forosa in the treatment of primary and secondary hyperparathyroidism of endocrine genesis are discussed.
Full Text
References
- Kanis J.A. On behalf of the World Health Organization Scientific Group (2007). Assessment of osteoporosis at the primary health-care level. Technical Report. World Health Organization Collaborating Centre for Metabolic Bone Diseases, University of Sheffield, UK. 2007: Printed by University of Sheffield.
- Лесняк О.М. Аудит состояния проблемы остеопороза в Российской Федерации // Профилактическая медицина. 2011; 14(2): 7-10.
- Остеопороз / Под ред. О.М. Лесняк, Л.И. Беневоленской. 2-е изд., перераб. и доп. (Серия «Клинические рекомендации»). М., 2011: 272 с.
- Торопцова Н.В., Никитинская О.А. Остеоскрининг Россия - социальная программа по выявлению риска переломов у населения: первые данные. Практикующий врач. 2012; 3: 45-48.
- Brandenburg V.M., Floege J. Adynamic bone disease- bone and beyond. NDT Plus 2008; 3: 135-47.
- Giachelli C.V. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-97.
- Cannata-Andia J.B., Roman-Garsia P., Hruska K. The connections between vascular calcification and bone health. Nephron. Dial. Transplant. 2011; 26: 3429-36.
- Дедов И.И., Рожинская Л.Я., Белая Ж.Е. Роль и место бисфосфонатов в профилактике и лечении остеопороза. 10-летний опыт применения алендроната. Остеопороз и остеопатии. 2005; 1: 20-30.
- Белая Ж.Е., Рожинская Л.Я. Бисфосфонаты: мифы и реальность. Эффективная фармакотерапия в эндокринологии. 2010; 9: 52-8.
Supplementary files
